CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for SurgiLight, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

SurgiLight, Inc.
12001 Science Dr Ste 140
Phone: (407) 482-4555p:407 482-4555 ORLANDO, FL  32826-2916  United States Fax: (407) 482-0505f:407 482-0505

This company's Plan of Liquidation went into effect on 7/12/2011
This company ceased filing statements with the SEC on 3/26/2008.
On 6/14/2012, the Company's bankruptcy case (#08-13851) was closed in the U.S. Bankruptcy Court for the Southern District of New York
This company is no longer actively traded on any major stock exchange.

Business Summary
SurgiLight, Inc. (SurgiLight) is engaged in selling ophthalmic lasers and related products and services based on its own and licensed intellectual property, primarily for use in refractive and presbyopia procedures. The Company’s target market is refractive surgery, particularly presbyopia, one of the last frontiers of ophthalmology. Presbyopia is a natural aging phenomenon where an aging person loses the ability to focus properly in the near vision field for reading. In October 2000, the Company acquired the ophthalmic laser product line from Premier Laser Systems, Inc (Premier). The acquisition also included an Er:YAG laser. The Company renamed the product as OptiVision and began formal animal and clinical studies for the treatment of presbyopia.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200712/31/2006YesYesYes-Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Operating Officer, Secretary Timothy J.Shea 54 1/1/2003 8/1/1999
Vice Chairman of the Board Louis P.Valente 81 1/1/2006 7/1/2001
Chief Financial Officer, Treasurer MarkMurphy 53
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 4 (As of 12/31/2006)
Outstanding Shares: 105,895,264 (As of 9/30/2007)
Shareholders: 231
Stock Exchange: OTC
Federal Tax Id: 351990562
Fax Number: (407) 482-0505


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023